Funding for this research was provided by:
Jiangsu Commission of Health (H2019087)
Wuxi Municipal Bureau on Science and Technology (N20192027)
Wuxi Health and Family Planning Commission (MS201901)
Received: 9 September 2022
Accepted: 24 December 2022
First Online: 24 January 2023
: This study was approved by our institutional review board, and patient informed consent was waived considering the retrospective nature of the study.
: Not applicable.
: Weiqiang Dou is an employee of GE Healthcare China. All remaining authors declare no competing interests.